期刊文献+

正畸保持期龈沟液骨保护素/核因子kappa B受体活化因子配体水平对牙槽骨改建状态的意义 被引量:2

Indication of osteoprotegerin(OPG) and receptor activator of nuclear factor kappa B ligand(RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention
暂未订购
导出
摘要 目的:探讨正畸保持期牙周龈沟液中骨保护素(osteoprotegerin,OPG)和核因子kappa B受体活化因子配体水平(receptor activator of nuclear factor kappa B ligand,RANKL)的变化及相应牙周组织OPG和RANKL表达的变化,为预测保持期牙周骨组织状态是否稳定提供依据。方法:选择6周龄雄性Wista大鼠15只,按时间点(T1:基线,T2:加力14 d,T3:停止加力14 d)分为3组,每组5只。在每个时间点先采集龈沟液样本,应用酶联免疫吸附试验(enzyme linked immunosorbent assay,ELISA)检测OPG和sRANKL(soluble receptor activator of nuclear factor kappaB ligand)浓度,然后处死大鼠,采用免疫组织化学检测牙周组织中OPG和RANKL表达。结果:龈沟液中sRANKL浓度在T2期明显上升(P<0.05),T3期则显著下降(P<0.05),与T1期几乎相当。龈沟液中OPG浓度在3个时间点的变化差异均无统计学意义(P>0.05);龈沟液中sRANKL/OPG的比值和牙周组织RANKL/OPG的比值变化近似,均在T2期明显增大(P<0.05和P<0.01),在T3期显著减小(P<0.05)。结论:在正畸加力至保持期,龈沟液中sRANKL/OPG的比值可以在一定程度上反映牙周组织中骨改建的状态。 Objective: To investigate the level of osteoprotegerin(OPG) and receptor activator of nuclear factor kappa B ligand(RANKL) in gingival crevicular fluid(GCF) during orthodontic retention and corresponding expression of OPG and RANKL in periodontal tissues.Methods: Fifteen male Wistar rats(age,6 weeks) were divided into three groups with 5 rats for each.GCF samples were collected at the baseline,14 days after orthodontic force application,and 14 days after orthodontic force removal.enzyme linked immunosorbent assay(ELISA) was used to quantify the concentration of OPG and sRANKL(soluble receptor activator of nuclear factor kappa B ligand) in GCF.Immunohistochemical staining was performed to identify the OPG and RANKL expression in periodontal tissues.Results: The concentration of sRANKL in GCF increased statistically significant from baseline to T2(P0.05) while decreased significantly from T2 to T3(P0.05).The concentration of OPG had minimum fluctuation from baseline to T3 without any statistical significance(P0.05).The sRANKL/OPG ratio in GCF and that in periodontal tissues during the three time points were similar which showed a prominent increase in T2(P0.05 and P0.01,respectively) and sharp decrease in T3(P0.05).Conclusion: sRANKL/OPG ratio may be one of the predictors reflecting the remodeling of periodontal tissues in orthodontic retention.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期108-112,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30801313)资助~~
关键词 正畸学 骨保护素 核因子KAPPA B受体活化因子 RANK配体 龈沟液 Orthodontics Osteoprotegerin Receptor activator of nuclear factor-kappa B RANK ligand Gingival crevicular fluid
  • 相关文献

参考文献8

二级参考文献72

  • 1张丁,李小彤.一种新型细胞加力实验装置的研制[J].中华口腔正畸学杂志,1999,15(3):112-113. 被引量:7
  • 2赵桂芝,吴军正,陈建元,王为.人牙周膜成纤维细胞的分离培养及其生物学特性的探讨[J].实用口腔医学杂志,1994,10(3):189-191. 被引量:17
  • 3[1]Hofbauer LC, Khosla S, Lacey DL, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res, 2000, 15: 2-12.
  • 4[2]Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin:a novel secreted protein involved in the regulation of bone density. Cell, 1997,89: 309-319.
  • 5[3]Tsuda E, Goto M, Mochizuki S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun, 1997,234:137-142.
  • 6[4]Hakeda Y, Kobayashi Y, Yamaguchi, et al. Osteoclastogenesis inhibitory factor(OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun,1998,251 : 796-801.
  • 7[5]Jager A. Histomorphometric study of age-related changes in remodelling activity of human desmodontal bone. J Anat, 1996,189: 257-264.
  • 8[6]King GJ, Latta L, Rutenberg J, et al. Alveolar bone turnover in male rats: site- and age-specific changes. Anat Rec, 1995,242 :321-328.
  • 9[7]Verna C, Zaffe D, Siciliani G. Histomorphometric study of bone reactions during orthodontic tooth movement in rats.Bone, 1999, 24: 371-379.
  • 10[8]Kabasawa M, Ejiri S, Hanada K, et al. Effect of age on physiologic and mechanically stressed rat alveolar bone: a cytologic and histochemical study. Int J Adult Orthod Orthognath Surg, 1996, 11: 313-327.

共引文献87

同被引文献19

  • 1Gandhi NS, Mancera RL. The structure of glycosaminoglycans and their interactions with proteins[J]. Chem Biol Drug Des, 2008,72 (6) :455-482.
  • 2Petitou M, Herauh JP, Bernat A, et al. Synthesis of thrombin- inhibiting heparin mimetics without side effects[J]. Nature, 1999,398 (6726) :417422.
  • 3Hulett MD, Freeman C, Hamdorf B J, et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis [J]. Nat Med, 1999,5(7) :803-809.
  • 4Walton K J, Duncan JM, Deschamps P, et al. Heparin acts synergistically with interleukin-11 to induce STA33 activation and in vitro osteoclast formation [ J ]. Blood, 2002,100 ( 7 ) : 2530-2536.
  • 5Zhang P, Wu Y, Jiang Z, et al. Osteogenic response of mesenchymal stem cells to continuous mechanical strain is dependent on ERK1/2-Runx2 signaling[J]. Int J Mol Med, 2012,29(6) :1083- 1089.
  • 6Chowdhury MH, Hamada C, Dempster DW. Effects of heparin on osteoclast activity[J]. J Bone Miner Res, 1992,7(7) :771-777.
  • 7Ariyoshi W, Takahashi T, Kanno T, et al. Heparin inhibits osteoclastic differentiation and function [ J ]. J Cell Biochem, 2008,103 (6) :1707-1717.
  • 8Shinmyouzu K, Takahashi T, Ariyoshi W, et al. Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF- kappa B ligand [ J ]. Biochem Biophys Res Commun, 2007,354 (2) :447-452.
  • 9Chang E J, Kim H J, Ha J, et al. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4 [J]. J Cell Sci, 2006,120 (Pt 1 ) : 166-176.
  • 10Ariyoshi W, Takahashi T, Kanno T, et al. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid [ J ]. J Biol Chem, 2005,280 ( 19 ) : 18967- 18972.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部